What would you ask ChinaPeptides (QYAOBIO) before a first order that they cannot fake?

I have kept every message, invoice and document, which I gather is the useful habit.

I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.

I have a working setup and a notebook, and I am prepared to be told that my setup is inadequate if that is the answer.

So: what is the actual procedure, and which steps matter as opposed to being ritual?

The short version: ask for the lot-specific certificate, check the method section, check the lot code ties to a vial, then spend a small amount and test it yourself.

Set your accept threshold before you see the result. Deciding after the number arrives is how thresholds become negotiable, and everybody does it unless they wrote it down first.

Cost per milligram, adjusted honestly

Published third-party data on a named lot is worth more than any aggregate rating, because it is about a specific object rather than about an average of other people's objects.

Write your accept threshold down before the result arrives.

A certificate without a method section is a claim rather than a measurement, and that distinction does most of the work here.

The pre-order sequence: request a lot-specific certificate for the exact line, check that it names a lot code rather than a batch family, check that it carries the column, gradient and detection wavelength, and check the analysis date is recent relative to the lot.

Ask what happens if a result comes back outside specification. The answer is informative regardless of what it is, and the question itself tells you something about how it lands.

The independent testing services this community references — Janoshik, Medutest, PeptideMeter and VendorInvestigate — publish results that can be searched by supplier, compound and date, which makes prior lots checkable.

The caveat is that a good result on one lot is a fact about that lot. It is a prior for the next one, not a guarantee.

Match the code on the glass to the code on the certificate. Everything else is secondary.

Answer first: vet the documentation before you vet the supplier, because documentation is the only thing you can assess before spending anything.

The post-arrival sequence: inspect before reconstitution, photograph anything unexpected, confirm the lot code is physically on the vial, and submit a sample to an independent laboratory before committing to a larger order.

To be exact about it, the single most informative free test is asking for the certificate of the lot they intend to ship and then confirming, on arrival, that the code on the glass matches it. A supplier who can do that has a traceability system; one who cannot does not.

Published inter-laboratory comparisons of peptide purity routinely find spreads of half a per cent to a per cent on identical material, which sets a realistic expectation for agreement.

Two lots agreeing is worth more than one lot excelling.

Stated carefully, reputation is a prior. An independent result on your own vial is the evidence.

Repeat the exercise on a second lot months later. Lot-to-lot agreement is the property that actually predicts your next order, and it cannot be established from one submission.

Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.

Small first order, independent submission, then scale. In that order.

The honest answer is that a small first order tested independently beats any amount of reading, and it costs less than most people expect.

Independent submission costs a fraction of a mid-sized order at any of the services this community uses, and it converts an opinion into a number attached to your own material.

Aggregate community ratings, including the one on this site, are opinion averages rather than measurements and should carry less weight than a single result on your own lot.

Ask for the lot-specific certificate before ordering. It is free and it is decisive.

edited 2 Mar 2026 by b_delacroix — updated for the 2026 guidance change